215 related articles for article (PubMed ID: 32012247)
1. Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients.
Garcia-Montojo M; Rodriguez-Martin E; Ramos-Mozo P; Ortega-Madueño I; Dominguez-Mozo MI; Arias-Leal A; García-Martínez MÁ; Casanova I; Galan V; Arroyo R; Álvarez-Lafuente R; Villar LM
Eur J Immunol; 2020 May; 50(5):685-694. PubMed ID: 32012247
[TBL] [Abstract][Full Text] [Related]
2. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.
Mameli G; Poddighe L; Mei A; Uleri E; Sotgiu S; Serra C; Manetti R; Dolei A
PLoS One; 2012; 7(9):e44991. PubMed ID: 23028727
[TBL] [Abstract][Full Text] [Related]
3. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.
Brudek T; Christensen T; Aagaard L; Petersen T; Hansen HJ; Møller-Larsen A
Retrovirology; 2009 Nov; 6():104. PubMed ID: 19917105
[TBL] [Abstract][Full Text] [Related]
4. Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression.
Pérez-Pérez S; Domínguez-Mozo MI; García-Martínez MÁ; García-Frontini MC; Villarrubia N; Costa-Frossard L; Villar LM; Arroyo R; Álvarez-Lafuente R
Front Immunol; 2021; 12():798003. PubMed ID: 34912348
[TBL] [Abstract][Full Text] [Related]
5. Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?
Antony JM; Deslauriers AM; Bhat RK; Ellestad KK; Power C
Biochim Biophys Acta; 2011 Feb; 1812(2):162-76. PubMed ID: 20696240
[TBL] [Abstract][Full Text] [Related]
6. Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis.
Mameli G; Poddighe L; Astone V; Delogu G; Arru G; Sotgiu S; Serra C; Dolei A
J Virol Methods; 2009 Oct; 161(1):98-106. PubMed ID: 19505508
[TBL] [Abstract][Full Text] [Related]
7. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.
Ruprecht K; Gronen F; Sauter M; Best B; Rieckmann P; Mueller-Lantzsch N
J Neurovirol; 2008 Apr; 14(2):143-51. PubMed ID: 18444086
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases.
Antony JM; Izad M; Bar-Or A; Warren KG; Vodjgani M; Mallet F; Power C
AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1253-9. PubMed ID: 17209768
[TBL] [Abstract][Full Text] [Related]
9. Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.
Laufer G; Mayer J; Mueller BF; Mueller-Lantzsch N; Ruprecht K
Retrovirology; 2009 Apr; 6():37. PubMed ID: 19368703
[TBL] [Abstract][Full Text] [Related]
10. HIV Tat acts on endogenous retroviruses of the W family and this occurs via Toll-like receptor 4: inference for neuroAIDS.
Uleri E; Mei A; Mameli G; Poddighe L; Serra C; Dolei A
AIDS; 2014 Nov; 28(18):2659-70. PubMed ID: 25250834
[TBL] [Abstract][Full Text] [Related]
11. Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
Chuluundorj D; Harding SA; Abernethy D; La Flamme AC
Immunol Cell Biol; 2014 Jul; 92(6):509-17. PubMed ID: 24638064
[TBL] [Abstract][Full Text] [Related]
12. Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
Curtin F; Perron H; Kromminga A; Porchet H; Lang AB
MAbs; 2015; 7(1):265-75. PubMed ID: 25427053
[TBL] [Abstract][Full Text] [Related]
13. Expression of human endogenous retrovirus-w including syncytin-1 in cutaneous T-cell lymphoma.
Maliniemi P; Vincendeau M; Mayer J; Frank O; Hahtola S; Karenko L; Carlsson E; Mallet F; Seifarth W; Leib-Mösch C; Ranki A
PLoS One; 2013; 8(10):e76281. PubMed ID: 24098463
[TBL] [Abstract][Full Text] [Related]
14. Human endogenous retrovirus envelope proteins target dendritic cells to suppress T-cell activation.
Hummel J; Kämmerer U; Müller N; Avota E; Schneider-Schaulies S
Eur J Immunol; 2015 Jun; 45(6):1748-59. PubMed ID: 25752285
[TBL] [Abstract][Full Text] [Related]
15. Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
Arru G; Leoni S; Pugliatti M; Mei A; Serra C; Delogu LG; Manetti R; Dolei A; Sotgiu S; Mameli G
Mult Scler; 2014 Feb; 20(2):174-82. PubMed ID: 23877972
[TBL] [Abstract][Full Text] [Related]
16. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
[TBL] [Abstract][Full Text] [Related]
17. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
Mameli G; Madeddu G; Mei A; Uleri E; Poddighe L; Delogu LG; Maida I; Babudieri S; Serra C; Manetti R; Mura MS; Dolei A
PLoS One; 2013; 8(11):e78474. PubMed ID: 24236019
[TBL] [Abstract][Full Text] [Related]
18. The important biological roles of Syncytin-1 of human endogenous retrovirus W (HERV-W) and Syncytin-2 of HERV-FRD in the human placenta development.
Gholami Barzoki M; Shatizadeh Malekshahi S; Heydarifard Z; Mahmodi MJ; Soltanghoraee H
Mol Biol Rep; 2023 Sep; 50(9):7901-7907. PubMed ID: 37421503
[TBL] [Abstract][Full Text] [Related]
19. Immune cell activation by trophoblast-derived microvesicles is mediated by syncytin 1.
Holder BS; Tower CL; Forbes K; Mulla MJ; Aplin JD; Abrahams VM
Immunology; 2012 Jun; 136(2):184-91. PubMed ID: 22348442
[TBL] [Abstract][Full Text] [Related]
20. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.
Balestrieri E; Minutolo A; Petrone V; Fanelli M; Iannetta M; Malagnino V; Zordan M; Vitale P; Charvet B; Horvat B; Bernardini S; Garaci E; di Francesco P; Sinibaldi Vallebona P; Sarmati L; Grelli S; Andreoni M; Perron H; Matteucci C
EBioMedicine; 2021 Apr; 66():103341. PubMed ID: 33867312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
